The mechanism by which the binding of a neurotransmitter to a receptor leads to channel opening is a central issue in molecular neurobiology. The structure of the agonist binding domain of ionotropic glutamate receptors has led to a greater understanding of the changes in structure that accompany agonist binding and have provided important clues as to the link between these structural changes and channel activation and desensitization. However, because the binding domain has exhibited different structures in different crystallization conditions, understanding the structure in the absence of crystal packing is of considerable importance. The orientation of the two lobes of the binding domain in the presence of a full agonist, an antagonist, and several partial agonists was measured using NMR spectroscopy by employing residual dipolar couplings. For some partial agonists the solution conformation differs from that observed in the crystal. A model of channel activation based on the results is discussed.The majority of excitatory synaptic transmission in the vertebrate central nervous system is mediated by ionotropic glutamate receptors (iGluRs; 3). These receptors also play important roles in neuronal development and the formation of synaptic plasticity underlying higher order processes such as learning and memory (4). In addition, iGluRs are also associated with neurologic disorders including epilepsy and ischemic brain damage and neurodegenerative disorders such as Huntington's chorea, Parkinson's and Alzheimer's diseases. iGluRs are membrane-bound receptor ion channels composed of four subunits surrounding a central ion channel in which each subunit contributes to pore formation. Subunits are categorized by pharmacological properties, sequence, functionality, and biological role into those that are sensitive: (1) to the synthetic agonist α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA 1 ; GluR1-4); (2) to the naturally occurring neurotoxin kainate (GluR5-7, KA1, 2); and (3) to the synthetic agonist N-methyl-D-aspartic acid (NMDA; NR1, NR2A-D, NR3A-B).The three dimensional structures of the binding domain (S1S2) of a number of glutamate receptors are known from X-ray crystallography. In particular, the structures of GluR2 bound to a wide variety of agonists, partial agonists and antagonists have provided compelling clues *Corresponding author; telephone: 1-607-253-3877; fax: 1-607-253-3659; reo1@cornell.edu. Supporting Information Available This material is available free of charge via the Internet at http://pubs.acs.org. 1 Abbreviations: AMPA, α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid; BrW, (S)-5-bromowillardiine; ClW, (S)-5-chlorowillardiine; FW, (S)-5-fluorowillardiine; HW, (S)-willardiine ((S)-2-Amino-3-(3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl) propanoic acid); iGluR, ionotropic glutamate receptor; IW, (S)-5-iodowillardiine; IPTG, isopropyl-β-D-thiogalactoside; NW, (S)-5-nitrowillardiine; NMDA, N-methyl-D-aspartic acid; S1S2, extracellular ligand-binding domain of GluR2; RDC, r...